Dan Mangan is a reporter covering health care and other issues for CNBC.com.
Mangan has been a journalist for more than 20 years, most recently as a general assignment/rewrite reporter at the New York Post. In his more than dozen years at The Post, Mangan routinely covered major stories, including the 9/11 terror attacks, the Bernard Madoff Ponzi scheme, the 2008 financial meltdown and a slew of juicy Gotham scandals du jour, among them the personal tribulations of Yankee slugger Alex Rodriguez.
Prior to that, Mangan began his career in his native Connecticut, writing obituaries for The Hour of Norwalk, before moving on to cover business, government and the court systems at The Hour, the Fairfield County Business Journal and The Advocate of Stamford.
Senate Republicans so far have presented three different versions of an Obamacare replacement bill.
The news comes after President Donald Trump pushed Republican senators to reach an agreement on a measure before the August recess.
Shkreli is accused of using sham settlement and consulting agreements from his drug company to pay off investors he allegedly defrauded.
"Your husband had stolen $1.6 million from me and I will get it back. I will go to any length necessary to get it back," Shkreli wrote.
Timothy Pierotti has said Shkreli harassed him and his family in a bid to get back more than 350,000 Retrophin shares.
John Neill said Shkreli waited nearly half a year to tell him his investment stake had dropped more than 40 percent.
Corey Massella said the accounting firm resigned from working for Retrophin after getting abusive emails from Shkreli about their work.
Martin Shkreli "doesn't seem to see other people as important if they don't fit into the scheme of what he wants," said Retrophin's CEO.
Steven Aselage testified that Shkreli was "a unique talent" who at times was "not as credible as he could have been."
Trump has been frustrated by the inability of his fellow Republicans in Congress to give him an Obamacare replacement bill to sign.